ELOVL7

Across TCGA pan-cancer cohorts, ELOVL7 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ELOVL7’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where ELOVL7 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types ELOVL7 is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

CCRCC and PDAC are the cancer types where ELOVL7 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELOVL7 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	III,IV	+0.479	<.001	7	view →
PDAC	All	All	−0.503	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

ELOVL7–CCRCC

Open the CCRCC breakdown →